홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Diisopropylethylamine → methyl 4-ethyl-2-formyl-5-[3-(trimethylsilyl)prop-1-ynyl]-1H-pyrrole-3-carboxylate

HRID 1785007
인쇄

반응식

HRID 1785007 반응식
CCN(C(C)C)C(C)C.[CH3:10][Si:11]([CH3:16])([CH3:15])[CH2:12][C:13]#[CH:14].[CH2:17]([C:19]1[C:20]([C:27]([O:29][CH3:30])=[O:28])=[C:21]([CH:25]=[O:26])[NH:22][C:23]=1I)[CH3:18]>C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.[Pd].[Pd].[Cu]I.O1CCOCC1>[CH2:17]([C:19]1[C:20]([C:27]([O:29][CH3:30])=[O:28])=[C:21]([CH:25]=[O:26])[NH:22][C:23]=1[C:14]#[C:13][CH2:12][Si:11]([CH3:16])([CH3:15])[CH3:10])[CH3:18]
참가 물질반응 조건실험 절차후처리출처 및 근거반응 노트

참가 물질

7

반응물 3

HCID 81531DiisopropylethylamineHCID 83378Trimethyl-2-propynylsilaneHCID 11278208Methyl 4-ethyl-2-formyl-5-iodo-1H-pyrrole-3-carboxylate

생성물 1

HCID 11335299methyl 4-ethyl-2-formyl-5-[3-(trimethylsilyl)prop-1-ynyl]-1H-pyrrole-3-carboxylate

시약·촉매·용매 3

HCID 24350Copper(1+) iodide; Copper(I) iodide; Cuprous iodide; Cuprous iodide (CuI)
촉매
HCID 9811564Bis(dibenzylideneacetone)palladium촉매
HCID 312751,4-Dioxane용매

반응 조건

온도
80 °C

실험 절차

Methyl 4-ethyl-2-formyl-5-iodo-1H-pyrrole-3-carboxylate was obtained following the procedures described in Example 3. Pd(Pt-Bu3)4 (18.4 mg, 0.040 mmol), Pd2(dba)3 (16.5 mg, 0.020 mmol), and CuI (4.6 mg, 0.020 mmol) were combined in a dry flask under N2 prior to evacuating the flask and refilling with argon. After the flask was charged with dioxane (4.0 mL), i-Pr2NEt (0.0675 mL, 0.48 mmol), trimethyl(prop-2-ynyl)silane (90.0 mg, 0.80 mmol), and methyl 4-ethyl-2-formyl-5-iodo-1H-pyrrole-3-carboxylate (123.0 mg, 0.40 mmol) were added sequentially. The reaction was stirred overnight at 80° C. After the reaction was cooled to ambient temperature, it was filtered through a plug of silica gel and concentrated in vacuo. The resultant residue was dissolved in acetonitrile and purified by reverse phase HPLC. Proton NMR for the product was consistent with the title compound. 1H NMR (500 MHz, CDCl3) δ 10.04 (s, 1H); 3.90 (s, 3H); 2.78 (q, J=7.5 Hz, 2H); 1.77 (s, 2H); 1.16 (t, J=7.5 Hz, 3H); 0.17 (s, 9H). HRMS (ES) exact mass calculated C15H22NO3Si (M+H): 292.1364. Found 292.1364

후처리

  1. customto evacuating the flask
  2. additionwere added sequentially
  3. temperatureAfter the reaction was cooled to ambient temperature
  4. filtrationit was filtered through a plug of silica gel
  5. concentrationconcentrated in vacuo
  6. dissolutionThe resultant residue was dissolved in acetonitrile
  7. custompurified by reverse phase HPLC

출처 및 근거

ORD 기록
ord-5f4d8741ddbd431a8594357909836278
출처 데이터셋
uspto-grants-2009_03
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US07504429B2

반응 노트

이 페이지에서참가 물질반응 조건실험 절차후처리출처 및 근거반응 노트